Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 876 M833 M1.01 B891 M168 M489 M 2.56 B Non-Operating Income, Total -257 M-190 M269 M-2 M-169 M306 M 404 M Interest expense, net of interest capitalized 44 M49 M47 M43 M49 M42 M 181 M Non-Operating Income, excl. Interest Expenses -301 M-239 M222 M-45 M-218 M264 M 223 M Unusual income/expense —————— — Pretax income -258 M192 M337 M209 M20 M280 M 846 M Equity in earnings —————— — Taxes -55 M38 M119 M-104 M17 M72 M 104 M Non-controlling/minority interest 3 M2 M-1 M——— — After tax other income/expense —————— — Net income before discontinued operations -232 M152 M219 M368 M-1 M204 M 790 M Discontinued operations 26 M———00 — Net income -206 M152 M219 M368 M-1 M204 M 790 M Dilution adjustment 000—00 — Preferred dividends 30 M11 M11 M—6 M6 M — Diluted net income available to common stockholders -236 M141 M208 M356 M-7 M198 M 755 M Basic earnings per share (Basic EPS) —————— — Diluted earnings per share (Diluted EPS) —————— — Average basic shares outstanding —————— — Diluted shares outstanding —————— — EBITDA 928 M871 M1.05 B1.39 B207 M275 M 2.91 B EBIT 876 M833 M1.01 B1.85 B168 M489 M 3.51 B Cost of revenue 1.19 B1.14 B891 M-65 M1.23 B987 M 3.04 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 52 M38 M35 M45 M39 M-214 M -95 M